Kuros Biosciences AG
Kuros is engaged in the development of orthobiologics and sealant products for tissue repair and regeneration.
Business Model:
Revenue: $726.2k
Employees: 11-50
Rankings
Industries / Tags:
Detailed Kuros Biosciences AG Information
Geographic Data
Address: Wagistrasse 25
City: Schlieren
State: zurich
Zip: 8952
Country: CH
Financial Info
Stage:
post ipo equity
Raised Last:
$16M
Raised Total:$25M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kuros is engaged in the development of orthobiologics and sealant products for tissue repair and regeneration.
Contact Phone:
Contact Email:
Kuros Biosciences AG went public on 1/22/2016 on the SIX Swiss Exchange
Listed Exchange:
SIX Swiss Exchange
IPO Date:
1/22/2016
Ticker Symbol:
KURN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 12/2016 | Xpand Biotechnology |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
